Brief Introduction of Synergy Pharmaceuticals Inc.
Listed in (NASDAQ:SGYP)
Synergy Pharmaceuticals Inc. globally headquarters situated on both Australia and the United States.
Synergy Pharmaceuticals was founded in 2007. The company's global research activities are called "Synergy Medical Research (SMR)".
MD of the company is Dr Edwards (General Practitioner).
Synergy produces a drug called Trulence or Plekonotide, which is used to treat irritable bowel syndrome and constipation.
News: As the COVID-19 virus has been declared a global pandemic, we would like to share some important information about the steps we are taking to support you in this indefinite period.
Synergy Pharmaceuticals about us page of LinkedIn, where you can collect more information.
The Customer Support Team apologizes in advance for the delay in responding to questions for general information. We want to make sure we are open and active to our customers and partners. Warm wishes to you and your family for good health.
Synergy has partnered with DHL to provide deliveries to almost all countries in the world. Synergy has sincerely apologized for recent issues with USPS and Royal Mail, which have resulted in delayed deliveries.
Everything that has been clinically tested and proven for the eradication of the herpes simplex virus is now available.
All of these are natural, targeting the source of the virus by boosting immunity, requiring no prescription. Results repeatedly show that this is the first product in the world to completely eradicate herpes (HSV-1 & HSV-2).
At the Third Global Expert Conference on Infectious Diseases in January 2020, we are pleased that "the isolation and eradication of the herpes simplex virus are hidden and removed from the sacral and trigeminal ganglion."
Synergy produces a drug called Trulence or Plekonotide, which is used to treat irritable bowel syndrome and constipation.
The USPTO (United States Patents Trademark Office) has issued three new patents for production methods, formulations and methods of using pleconatide.
The European Patent Office (EPO) has also issued patents for pleconazole.
Synergy will not send new orders until the end of August, as more orders are currently being processed to handle high-end services. Pre-orders can still be placed and will be shipped after August 5th.
The first phase clinical trial for pleconazole (first proprietary SP drug SP-304) began in June 2008. Since February 2010, multi-stage clinical trials, including the CIC 3 and National CIC 3 trials, have begun.
Synergy will not send new orders until the end of August, as more orders are currently being processed to handle high-end services. Pre-orders can still be placed and will be shipped after August 5th.
The first phase clinical trial for pleconazole (first proprietary SP drug SP-304) began in June 2008. Since February 2010, multi-stage clinical trials, including the CIC 3 and National CIC 3 trials, have begun.
The latest Phase II trial for CIC was completed in March 2016. Multi-stage III trials for pleconotide for IBS-C references were also conducted, most recently completed in June 2017.
Ultimate Immune System Combination. There is now a new approach to stop herpes.
Ultimate Immune System Combination. There is now a new approach to stop herpes.
News: As the COVID-19 virus has been declared a global pandemic, we would like to share some important information about the steps we are taking to support you in this indefinite period.
Synergy Pharmaceuticals about us page of LinkedIn, where you can collect more information.
The Customer Support Team apologizes in advance for the delay in responding to questions for general information. We want to make sure we are open and active to our customers and partners. Warm wishes to you and your family for good health.
Synergy has partnered with DHL to provide deliveries to almost all countries in the world. Synergy has sincerely apologized for recent issues with USPS and Royal Mail, which have resulted in delayed deliveries.
Everything that has been clinically tested and proven for the eradication of the herpes simplex virus is now available.
All of these are natural, targeting the source of the virus by boosting immunity, requiring no prescription. Results repeatedly show that this is the first product in the world to completely eradicate herpes (HSV-1 & HSV-2).
Herpes does not suppress the virus, but it eliminates it completely, leaving no clinical signs of the virus.
At the Third Global Expert Conference on Infectious Diseases in January 2020, we are pleased that "the isolation and eradication of the herpes simplex virus are hidden and removed from the sacral and trigeminal ganglion."
Synergy is pleased to announce their contribution to Virus 2020 - Novel Concepts in Virology on February 5 to 7, 2020 in Barcelona, Spain.
Viral diseases have reached epidemic proportions. Viruses are the biggest public health threat that is yet to be faced in the world, much less is being done to address the current epidemic of viruses that entice humans to one thing. The common synergy among all of us is the desire to be pharmaceutical.
Viral diseases have reached epidemic proportions. Viruses are the biggest public health threat that is yet to be faced in the world, much less is being done to address the current epidemic of viruses that entice humans to one thing. The common synergy among all of us is the desire to be pharmaceutical.
The synergy is moving towards providing people with the best access to natural health treatments in collaboration with global science, moving targets to improve health outcomes for populations worldwide.
The synergies are thus focused on critical manufacturing operations to build upon and expand on the results achieved.
Having delivered on excellence by ensuring only certified organic agricultural production and operating standards, we have been awarded a carbon-neutral rating in our agriculture and manufacturing divisions, opening up the secrets of nature to meet today's health challenges.
It is a synergy of research and development in viral infections. It has revolutionized the medical industry's approach to viral diseases offering hope through innovative research and others to destroy the virus by incorporating the latest in scientific research with the benefits of natural plant products.
That allows for a product that has brought more results than any man-made one. Antiviral medicine has been notable prior to our results in the treatment of herpes simplex virus.
Our product divisions have been rapidly expanded to provide products to meet the progress of recognition and achievements for all genders.
And the core value for all members of the public is diversity organizational education and focused people with an emphasis on the importance of equipping people and supporting their people as we embrace values and trust and create a seamless customer Are able to trust another.
The ducts affected by viral diseases capable of changing the service experience and improving the lives of the freed from the spread of diseases to eliminate disease burden and prevent infection cycle.
Synergy Pharmaceuticals has been selected to participate in the International Conference on Immunization and Diagnosis of Viral Infections in the Tokyo Japan 2020.
There is nothing worse than not knowing when the next outbreak or cold sore will come. This is not to say that you have the disease and that it can make your sex life miserable. Most people are not aware that the herpes virus can cause serious illness in the internal organs and brain.
The main ingredient in this combination is our amino acid formula, which can be used to treat other serious health conditions. The Herald is one of the most powerful antioxidant immune systems ever developed.
As an Australian company, Synergy submits its products to rigorous testing and certification to ensure that they are safe for public use. All products contain 100% natural health ingredients, not prescription drugs.
As a supplier, Synergy is required to meet all regulatory requirements for the manufacture, testing, labelling and certification of our products. The range of plant-based products is non-GMO, organic and manufactured for high production.
Synergy Pharmaceuticals Australia continues to be financially strong and profitable as it expands into our domestic and international research, distribution and manufacturing sectors.
Synergy Pharmaceuticals has been selected to participate in the International Conference on Immunization and Diagnosis of Viral Infections in the Tokyo Japan 2020.
There is nothing worse than not knowing when the next outbreak or cold sore will come. This is not to say that you have the disease and that it can make your sex life miserable. Most people are not aware that the herpes virus can cause serious illness in the internal organs and brain.
The main ingredient in this combination is our amino acid formula, which can be used to treat other serious health conditions. The Herald is one of the most powerful antioxidant immune systems ever developed.
As an Australian company, Synergy submits its products to rigorous testing and certification to ensure that they are safe for public use. All products contain 100% natural health ingredients, not prescription drugs.
As a supplier, Synergy is required to meet all regulatory requirements for the manufacture, testing, labelling and certification of our products. The range of plant-based products is non-GMO, organic and manufactured for high production.
Synergy Pharmaceuticals Australia continues to be financially strong and profitable as it expands into our domestic and international research, distribution and manufacturing sectors.
0 Comments